(Login BolsaPT & Canal Forex) |
|
 Sepracor Inc. - [Ticker: SEPR] |     | | Última Trade | | Range 52 Semanas | [0,000 - 0,000] | | Hora da Última Trade | N/A - N/A | Price-Target 1 Ano | N/A | | Variação | () | Capitalização Bolsista | 3 | | Bid / Ask | N/A | EPS | 0,00 | | Abertura | | PER | 12,69% | | Máximo | | Pagamento Dividendo | N/A | | Mínimo | | Data Ex-Dividendo | N/A | | Fecho Anterior | 0,000 | Yield | N/A | | Volume | | Volume Médio (3m) | 0 | | Nota: Os dados podem apresentar atraso de alguns minutos. |
| | Ver cotações de outros activos |
| Últimos 10 Tópicos no Fórum sobre Sepracor Inc.: | | Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc.. |
|
Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)
| |
Asthma Medication Market 2017 ? Dulera, QVAR, Genentech Inc, Sepracor, IncFirst News ServiceWorldwide Asthma Medication Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Asthma Medication piece of the overall industry and Growth patterns, concentrating on driving Asthma ...e mais » |
|
Thinking About the Assessment of Risk: September 2017HealioAndrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ... |
|
New report shares details about the asthma medication market forecast to 2022WhaTechDulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The report also details the market positioning, ...e mais » |
|
Desloratadine Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic ...MilTechDesloratadine Market Key Players Analysis: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...e mais » |
PR Newswire (press release) |
Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...PR Newswire (press release)Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...e mais » |
|
Sunovion Pharmaceuticals Inc. Announces Company Name ChangeBusiness Wire (press release)BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...e mais » |
Reuters |
Dainippon to buy US drug firm Sepracor for $2.6 billionReutersSepracor, based in Marlborough, Massachusetts, had 2008 sales of $1.3 billion. Financial advisers to Dainippon Sumitomo were Nomura Securities and Thomas Weisel Partners LLC, while JP Morgan Securities Inc and Jeffries & Co advised Sepracor. |
|
Sunovion Celebrates Five-Year Anniversary MilestoneBusiness Wire (press release)MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...e mais » |
| Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. |
|
![Gráfico de Sepracor Inc. - [Ticker: SEPR]](http://www.bolsapt.com/grafico/bolsapt-SEPR-6-meses.png "Gráfico 6 Meses de Sepracor Inc. [SEPR] BolsaPT")
